Skip to main content
Clinical Trials/NCT04568512
NCT04568512CompletedNot Applicable

DNA Methylation Biomarker in Biliary Brush Sample for Diagnosis of Cholangiocarcinoma in Patients With Bile Duct Stricture

Mahidol University1 site in 1 country67 target enrollmentStarted: January 1, 2016Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
67
Locations
1
Primary Endpoint
The methylation of HOXA1, NEUROG1 were determined in brushed biliary samples from patients with CCAs compared to those of nonmalignant bile duct stricture

Study Overview

Brief Summary

DNA methylation biomarker for diagnosis of cholangiocarcinoma in patients with bile duct stricture has high sensitivity and specificity compared with cytology from the brush specimens

Detailed Description

The methylation of HOXA1, NEUROG1 were used to determine cholangiocarcinoma from brushed biliary samples. However, the sensitivity and specificity of this test for cholangiocarcinoma is still required.

Study Design

Study Type
Interventional
Allocation
Non Randomized
Intervention Model
Parallel
Primary Purpose
Diagnostic
Masking
Single (Participant)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Age more than 18 year old
  • •Patients had biliary stricture from cholangiocarcinoma and benign stricture

Exclusion Criteria

  • •Pregnancy
  • •Patient had other malignancy

Arms & Interventions

Control

Placebo Comparator

Brushed biliary samples from a known case of benign biliary stricture were sent for DNA Methylation Biomarker test and cell cytology

Intervention: Control (Diagnostic Test)

Cholangiocarcinoma

Active Comparator

Brushed biliary samples from a known case of cholangiocarcinoma were sent for DNA Methylation Biomarker test and cell cytology

Intervention: Cholangiocarcinoma (Diagnostic Test)

Outcomes

Primary Outcomes

The methylation of HOXA1, NEUROG1 were determined in brushed biliary samples from patients with CCAs compared to those of nonmalignant bile duct stricture

Time Frame: 2 weeks

Methylation index of biliary brush samples were analyzed.

Secondary Outcomes

  • Sensitivity, specificity of DNA methylation for diagnosis of cholangiocarcinoma(2 weeks)
  • To compared sensitivity, specificity of DNA methylation with routine cytology of biliary brushed samples(2 weeks)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials